India approves first new cancer pneumonia treatment drug, Favilavir.
-
Last Update: 2020-07-20
-
Source: Internet
-
Author: User
Search more information of high quality chemicals, good prices and reliable suppliers, visit
www.echemi.com
Glenmark has developed its own apilavion sorage (API) and formulationsAs a prescription drug, the recommended dose of FabiFlu is 1800 mg on the 1st day (2 times per day) and 800 mg on the 2nd-14th day (2 times per day)Glenn Saldanha, Chairman of the Glenmark Board of Directors, said: "The dramatic increase in COVID-19 cases in India poses a huge challenge to our health care systemIt is hoped that FabiFlu's launch will help ease this pressure and provide Indian patients with much-needed treatment optionsOn February 16,, Haizheng Pharmaceuticals also issued a notice announcing receipt of the Drug Registration Approval approved by the State Drug Administration for the treatment of new or recurrent influenza in adults (only when other anti-flu virus drugs are ineffective or ineffective) and the "Pharmaceutical Clinical Trial Approval" approved for favilave tablets for clinical trials of new coronavirus pneumonia.
This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only.
This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of
the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed
description of the concern or complaint, to
service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content
will be removed immediately.
